Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample
- PMID: 33855757
- DOI: 10.1111/dar.13298
Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample
Abstract
Introduction: Several questionnaires have been developed for screening cannabis use disorder in clinical populations, but very few studies have compared the screening abilities of the different instruments. Here, we aimed to confirm the psychometric properties of a French version of the Cannabis Use Disorder Identification Test-Revised (CUDIT-R), and to compare its screening abilities with those of the Cannabis Abuse Screening Test (CAST), in subjects consulting in mental health settings.
Methods: Two hundred and thirteen cannabis smokers who sought treatment for any type of mental disorder, recruited in four French centres, completed the French CUDIT-R (CUDIT-R-Fr) and the full version of the CAST, and were assessed for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria of cannabis use disorder by an addiction specialist. They were retested with the CUDIT-R-Fr after approximately a week. The factorial construct validity, internal consistency and test-retest reliability of the CUDIT-R-Fr were assessed. The compared sensitivity and specificity of the CAST and CUDIT-R-Fr were explored, using the clinician assessment as the reference.
Results: The French CUDIT-R showed a good internal consistency (Cronbach's alpha = 0.89) and an excellent test-retest reliability (ρ = 0.97). The sensitivity and specificity for screening cannabis use disorder were 0.81 and 0.77 for the CUDIT-R, and 0.92 and 0.63 for the CAST, respectively.
Conclusions: Based on the recommended cut-offs, the CAST appeared more sensitive, while the CUDIT-R was more specific, for screening cannabis use disorder in a population of cannabis users with heterogeneous types of mental health disorders.
Keywords: cannabis; cannabis use disorder; psychiatric populations; psychometrics; screening.
© 2021 Australasian Professional Society on Alcohol and other Drugs.
Similar articles
-
[Screening tools for cannabis use disorders and their adaptation to DSM-5: A literature review].Encephale. 2020 Oct;46(5):382-389. doi: 10.1016/j.encep.2020.02.010. Epub 2020 May 28. Encephale. 2020. PMID: 32475691 Review. French.
-
Evaluation of the psychometric properties of the cannabis use disorders identification test - revised among college students.Addict Behav. 2019 Aug;95:11-15. doi: 10.1016/j.addbeh.2019.02.016. Epub 2019 Feb 18. Addict Behav. 2019. PMID: 30798191
-
Assessment of the validity of the CUDIT-R in a subpopulation of cannabis users.Am J Drug Alcohol Abuse. 2018;44(1):19-23. doi: 10.1080/00952990.2017.1376677. Epub 2017 Oct 23. Am J Drug Alcohol Abuse. 2018. PMID: 29058471
-
Assessing the diagnostic utility of the Cannabis Use Disorder Identification Test - Revised (CUDIT-R) among veterans with medical and non-medical cannabis use.Drug Alcohol Depend. 2023 Jun 1;247:109876. doi: 10.1016/j.drugalcdep.2023.109876. Epub 2023 Apr 14. Drug Alcohol Depend. 2023. PMID: 37130467
-
Short scales to assess cannabis-related problems: a review of psychometric properties.Subst Abuse Treat Prev Policy. 2008 Dec 2;3:25. doi: 10.1186/1747-597X-3-25. Subst Abuse Treat Prev Policy. 2008. PMID: 19055741 Free PMC article. Review.
Cited by
-
Alterations in self-reported sensory gating and interoception in individuals frequently using cannabis.Am J Drug Alcohol Abuse. 2024 Jul 3;50(4):525-535. doi: 10.1080/00952990.2024.2332602. Epub 2024 Apr 2. Am J Drug Alcohol Abuse. 2024. PMID: 38563523 Free PMC article.
-
Smoking Mostly Alone as a Risk Factor for Cannabis Use Disorders and Depressive Symptoms.Int J Ment Health Addict. 2022 Nov 17:1-10. doi: 10.1007/s11469-022-00956-1. Online ahead of print. Int J Ment Health Addict. 2022. PMID: 36415673 Free PMC article.
-
Psychometric properties of the cannabis abuse screening test (CAST) in a sample of Moroccans with cannabis use.Addict Sci Clin Pract. 2024 Apr 3;19(1):24. doi: 10.1186/s13722-024-00459-5. Addict Sci Clin Pract. 2024. PMID: 38570799 Free PMC article.
-
Association between family functioning and psychotic transition in ultra-high risk adolescents and young adults.Front Psychiatry. 2023 Jun 21;14:1177311. doi: 10.3389/fpsyt.2023.1177311. eCollection 2023. Front Psychiatry. 2023. PMID: 37415693 Free PMC article.
References
-
- United Nations. World drug report 2019 [internet]. 2019. Available at: https://wdr.unodc.org/wdr2019/ (accessed 21 November 2019).
-
- National Academies of Sciences, Engineering, and Medicine. The health effects of cannabis and cannabinoids: the current state of evidence and recommendations for research. Washington, DC: The National Academies Press, 2017 Available at: https://doi.org/10.17226/24625.
-
- Kroon E, Kuhns L, Hoch E, Cousijn J. Heavy cannabis use, dependence and the brain: a clinical perspective. Addiction 2020;115:559-72.
-
- Hall W, Stjepanović D, Caulkins J et al. Public health implications of legalising the production and sale of cannabis for medicinal and recreational use. Lancet 2019;394:1580-90.
-
- López-Pelayo H, Batalla A, Balcells MM, Colom J, Gual A. Assessment of cannabis use disorders: a systematic review of screening and diagnostic instruments. Psychol Med 2015;45:1121-33.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous